Ionis Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
IONS Ionis Pharmaceuticals Inc
CCL Carnival Corp
CLPR Clipper Realty Inc
VGI Virtus Global Multi-Sector Income Fund
VDE Vanguard Energy Index Fund ETF Shares
VCV Invesco California Value Municipal Income Trust
VCSH Vanguard Short-Term Corporate Bond Index Fund ETF Shares
VBR Vanguard Small-Cap Value Index Fund ETF Shares
V Visa Inc
UPS United Parcel Service Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform, has developed a pipeline of drugs for patients with unmet medical needs. The Company's segments include Ionis Core and Akcea Therapeutics. In the Ionis Core segment, the Company is engaged in exploiting a drug discovery platform to generate a pipeline of drugs for the Company and its partners. The Akcea Therapeutics segment includes the operations of the Company's subsidiary, Akcea Therapeutics, Inc. (Akcea Therapeutics). Akcea Therapeutics is focused on developing and commercializing volanesorsen and other clinical-stage drugs for serious cardiometabolic diseases caused by lipid disorders. The Company is developing volanesorsen to treat two severe and rare, genetically defined diseases, familial chylomicronemia (FCS) and familial partial lipodystrophy (FPL). The Company offers SPINRAZA, a Generation 2.0+ antisense drug.

Closing Price
$60.20
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
935,372
0
  • Prev Close
    60.20
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    935.4K
  • Last (time)
    4:00p ET 07/01/20
  • Last (size)
    2.0K
  • 52-Wk Range
    39.32 - 73.09
    LowHigh
  • (08/21/19 - 03/23/20)
    17.64%
  • 43.0%
  • Market Cap
    8.4B
  • Shares Outstanding
    139.3M
  • 1.12
  • 53.76x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 84.70
  • (% of float 06/15/20)
    6.92

Latest News

June 29, 2020
7:00 am ET
PR Newswire
June 17, 2020
7:00 am ET
PR Newswire
June 09, 2020
7:00 am ET
PR Newswire
June 08, 2020
7:00 am ET
PR Newswire
June 05, 2020
7:05 am ET
PR Newswire
May 28, 2020
4:05 pm ET
PR Newswire
7:00 am ET
Globe Newswire
May 18, 2020
7:00 am ET
PR Newswire
May 14, 2020
4:05 pm ET
PR Newswire
May 07, 2020
7:01 am ET
PR Newswire
May 06, 2020
7:00 am ET
PR Newswire
May 05, 2020
4:05 pm ET
PR Newswire
May 01, 2020
7:05 am ET
PR Newswire
April 29, 2020
12:35 pm ET
Globe Newswire
April 22, 2020
7:05 am ET
PR Newswire
April 21, 2020
7:04 am ET
Globe Newswire
April 20, 2020
7:05 am ET
PR Newswire
April 08, 2020
7:05 am ET
PR Newswire
April 07, 2020
7:05 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.